Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Contemp Clin Trials. 2020 Dec 7;101:106242. doi: 10.1016/j.cct.2020.106242

Table 2.

Study Outcome Measures

Assessment Measurement Instrument
Primary Outcomes
Chemotherapy dosing and completion rates (RDI) Medical record
Patient-reported chemotherapy-associated toxicities NCI PRO CTCAE survey
Secondary Outcomes
Body composition DXA
Inflammatory blood markers Serum blood samples
Chemotherapy-associated toxicities Medical record
Patient-reported chemotherapy-associated toxicities EORTC CIPN20 questionnaire